Phosphodiesterase Inhibitors, Pentoxifylline, as Adjunctive Therapy in Patients With Ulcerative Colitis.
NCT05575505
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
44
Enrollment
OTHER
Sponsor class
Conditions
Inflammatory Bowel Diseases
Interventions
DRUG:
Pentoxifylline 400 MG
Sponsor
Tanta University